ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1717 • 2017 ACR/ARHP Annual Meeting

    Skin Commensal Bacteria Might Affect Wound Repair in SSc By Preventing Fibroblast Activation and By Provoking Chronic Inflammatory Reaction

    Masaya Yokota1, Janine Schniering1, Oliver Distler2 and Britta Maurer3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland, Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Chronic digital ulcers (DU) due to peripheral microangiopathy are a major complication in systemic sclerosis (SSc). Chronic wounds are often enriched in bacteria without…
  • Abstract Number: 1718 • 2017 ACR/ARHP Annual Meeting

    The Role and Function of Monocyte-Derived Fibroblast-like Cells in Multi-Organ Fibrosis in Systemic Sclerosis

    Michal Rudnik1, Mara Stellato1, Vincent Milleret2, Przemyslaw Blyszczuk1,3, Britta Maurer1, Karin Klingel4, Joerg C. Henes5, Karl Sotlar6, Martin Ehrbar2, Oliver Distler7 and Gabriela Kania1, 1Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland, 3Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland, 4Department of Molecular Pathology, University Hospital Tuebingen, Tuebingen, Germany, 5Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, 6Institute of Pathology, Ludwig Maximilians University, Munich, Germany, 7Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Animal studies indicated bone marrow-derived cells as a source of pathological myofibroblasts in fibrosis of multiple organ including lungs, heart, skin and kidney. Monocytes…
  • Abstract Number: 1719 • 2017 ACR/ARHP Annual Meeting

    Accelerated Wound Healing in Megakaryocyte/Platelet-Specific Fli1 Knockout Mice Due to the up-Regulated Expression of Interferon-γ

    Megumi Hirabayashi1, Yoshihide Asano2, Takashi Yamashita1, Ryosuke Saigusa1, Shunsuke Miura3, Kouki Nakamura1, Takuya Miyagawa1, Takashi Taniguchi1, Ayumi Yoshizaki1 and Shinichi Sato4, 1Dermatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan, 2Applied Chemistry, University of Tokyo, Graduate School of Medicine, Tokyo, Japan, 3University of Tokyo, Graduate School of Medicine, Tokyo, Japan, 4Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan

    Background/Purpose: Fli1 deficiency, a potential predisposing factor of systemic sclerosis (SSc), induces SSc-like phenotypes in dermal fibroblasts, endothelial cells, keratinocytes, and macrophages. However, it is…
  • Abstract Number: 1720 • 2017 ACR/ARHP Annual Meeting

    TGF-ß-Induced Tissue Fibrosis in TBRIcaCol1Cre Transgenic Mice Is Abrogated By the Second Generation Tyrosine Kinase Inhibitor SKI-606 (Bosutinib)

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center, Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Bosutinib (SKI-606), a second-generation tyrosine kinase inhibitor that blocks the activity of the BCR-ABL kinase responsible for Philadelphia chromosome positive chronic myeloid leukemias, also…
  • Abstract Number: 1721 • 2017 ACR/ARHP Annual Meeting

    Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGFβ-Driven Fibrotic Diseases

    Elena Pachera1, Adam Wunderlin1, Shervin Assassi2, Gloria Salazar2, Mojca Frank Bertoncelj1, Rucsandra Dobrota1, Matthias Brock3, Carol A. Feghali-Bostwick4, Gerard Dijkstra5, Gerhard Rogler6, Tobias van Haaften Wouter6, Jörg Distler7, Gabriela Kania1 and Oliver Distler1, 1Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 3Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland, 4Division of Rheumatology and Immunology, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, United States, Charleston, SC, 5Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Switzerland, 6Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, 7Internal Medicine 3, University of Erlangen, Erlangen, Germany

    Background/Purpose: Long noncoding RNAs (lncRNAs) are a class of transcripts regulating gene expression. We have recently identified a novel lncRNA, H19X, which was upregulated in…
  • Abstract Number: 1722 • 2017 ACR/ARHP Annual Meeting

    Identification of a Sub-Population of Autoantibodies Targeting BICD2 Cross-Reacting with CENP-a Derived Peptides in Patients with Systemic Sclerosis

    Michael Mahler1, Chelsea Bentow1, Jay Milo1, May Choi2, Mianbo Wang3, Petra Budde4, Murray Baron5, Marie Hudson6 and Marvin J. Fritzler7, 1Research and Development, Inova Diagnostics, San Diego, CA, 2University of Calgary, Calgary, AB, Canada, 3Lady Davis Institute for Medical Research, Montreal, QC, Canada, 4Protagen AG, Dortmund, Germany, 5Rheumatology, Jewish General Hospital, Montreal, QC, Canada, 6Division of Rheumatology, Jewish General Hospital, Lady David Institute for Medical Research, Montreal, QC, Canada, 7Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Anti-nuclear antibodies (ANA) are present in approximately 90% of sera from systemic sclerosis (SSc) patients and play an important role in the diagnosis and…
  • Abstract Number: 1723 • 2017 ACR/ARHP Annual Meeting

    Nuclear Magnetic Resonance Based Metabolomics Study Identifies Highly Discriminatory Metabolites in 87 Systemic Sclerosis Patients

    Sakir Ahmed1, Mohit Kumar Rai1, Durgesh Dubey2, Atul Rawat3, Dinesh Kumar3, Durga Prasanna Misra1 and Vikas Agarwal1, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Centre for Biomedical Research, PhD Student, Lucknow, India, 3Centre for Biomedical Research, Lucknow, India

    Nuclear Magnetic Resonance based Metabolomics Study Identifies Highly Discriminatory Metabolites in 87 Systemic Sclerosis Patients Background/Purpose: Proton based Nuclear Magnetic Resonance (1H NMR) can identify…
  • Abstract Number: 1724 • 2017 ACR/ARHP Annual Meeting

    Metabolic Regulation of Fibrosis in Systemic Sclerosis: The CD38-NAD+ Link

    Bo Shi1, Wenxia Wang1, Jun Wei2, Swati Bhattacharyya1, Benjamin Korman3, Eduardo Chini4 and John Varga5, 1Northwestern University, Chicago, IL, 2Northwestern University, chicago, IL, 3Department of Rheumatology, Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 4Kogod Center on Aging, Mayo Clinic, Rochester, MN, 5Rheumatology and Dermatology, Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL

    Background/Purpose: The anti-aging deacetylase enzymes SIRT1 and SIRT3 show potent anti-fibrotic activity, and their expression and function are markedly deregulated in patients with systemic sclerosis…
  • Abstract Number: 1725 • 2017 ACR/ARHP Annual Meeting

    Insulin-like Growth Factor Binding Protein-4 Exerts Anti-Fibrotic Effects and Its Levels Are Reduced in SSc-Associated Lung Fibrosis

    Yunyun Su1, Stanley Hoffman2 and Carol A. Feghali-Bostwick3, 1Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, charleston, SC, 2Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 3Division of Rheumatology and Immunology, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, United States, Charleston, SC

    Background/Purpose: The Insulin-like growth factor (IGF) system plays an important role in cellular growth, proliferation, differentiation, apoptosis and transformation; IGF binding proteins (IGFBP) exert cell…
  • Abstract Number: 1726 • 2017 ACR/ARHP Annual Meeting

    Human Skin in Organ Culture As an Ex Vivo Model for Assessing the Fibrotic Effects of Bleomycin

    Tomoya Watanabe1, Logan Mlakar2, Jonathan Heywood3, Maya Malaab2 and Carol A. Feghali-Bostwick4, 1Rheumatology, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC, 3Rheumataology, Medical University of South Carolina, Chareston, SC, 4Division of Rheumatology and Immunology, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, United States, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease of unknown etiology. Using human skin as an ex vivo organ model of fibrosis is an…
  • Abstract Number: 1727 • 2017 ACR/ARHP Annual Meeting

    Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of Interferon-Associated Genes in CD4+ and CD8+ T Cells

    Weilin Pu1, Weifeng Ding2, Lei Wang3, Shuai Jiang4, Wenzhen Tu3, Shicheng Guo5, Qingmei Liu6, Yanyun Ma4, Sidi Chen7, Wenyu Wu6, Xiaodong Zhou8, Maureen D. Mayes9, Shervin Assassi9, John D. Reveille9, Li Jin10 and Jiucun Wang10, 1State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences,, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China, 2Medical Laboratory Center, Medical Laboratory Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China, Nantong, China, 3Division of Rheumatology, Division of Rheumatology, Shanghai TCM-integrated Hospital, Shanghai, China, Shanghai, China, 4Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China, Shanghai, China, 5Department of Bioengineering, Department of Bioengineering, University of California at San Diego, CA, USA, San Diego, CA, 6Department of Dermatology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China, 7State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences,, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China, 8Internal Medicine-Rheumatology, University of Texas McGovern Medical School, Houston, TX, 9University of Texas McGovern Medical School, Houston, TX, 10State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, China, Shanghai, China

    Background/Purpose: Systemic sclerosis (SSc) is a complex systemic autoimmune disease caused by complicated interaction between genetic, epigenetic and environmental risk factors. Evidence showed epigenetic modifications,…
  • Abstract Number: 1728 • 2017 ACR/ARHP Annual Meeting

    Interferon Gamma (IFN-γ) Subpopulations in Skin Homing T Cells of Localized Scleroderma

    Claudia Macaubas1, Emily Mirizio2, Kaila Schollaert-Fitch3, Elizabeth D. Mellins4 and Kathryn S. Torok3, 1Department of Pediatrics, Program in Immunology, Stanford University Med Ctr, Stanford, CA, 2Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 3Pediatric Rheumatology, University of Pittsburgh Med Ctr, Pittsburgh, PA, 4Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA

    Background/Purpose: Localized scleroderma (LS) has both inflammatory and fibrotic components contributing to its effect on the skin and underlying tissue.   The understanding of the pathophysiology…
  • Abstract Number: 1729 • 2017 ACR/ARHP Annual Meeting

    Increased Serum Levels of Micro-RNA 30d and Micro-RNA 423-5p in 2 Independent Cohorts of Patients with Morphea

    Jorre S. Mertens1,2, Wiola Marut1, Cornelis P.J. Bekker1, Elke M.G.J. de Jong3 and Timothy R.D.J. Radstake1,4, 1Rheumatology and Clinical Immunology, Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Dermatology, Radboud University Medical Center, Nijmegen, Netherlands, 3Radboud University Medical Center, Nijmegen, Netherlands, 4Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose : Morphea, also known as localized scleroderma, encompasses a group of idiopathic sclerotic skin diseases. MicroRNAs (miRNAs) are a large family of highly conserved…
  • Abstract Number: 1730 • 2017 ACR/ARHP Annual Meeting

    IL-6 Mediates Activation of Macrophages in Patients with Systemic Sclerosis

    Rajan Bhandari1, Michael Ball2, Viktor Martyanov3, Dillon Popovich4, Mary A. Carns5, Kathleen Aren5, Monique Hinchcliff6, Michael L. Whitfield7 and Patricia A. Pioli8, 1Geisel School of Medicine at Dartmouth, lebanon, NH, 2Geisel School of Medicine at Dartmouth, Lebanon, NH, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Geisel School of Medicine at Dartmouth, hanover, NH, 5Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 6Rheumatology, Northwestern Medicine, Chicago, IL, 7Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 8Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH

    Background/Purpose: Activated macrophages (MØs) have been implicated as regulators of fibrosis in patients with systemic sclerosis (SSc), and we have shown that MØs from SSc…
  • Abstract Number: 1731 • 2017 ACR/ARHP Annual Meeting

    Abnormal Responses of  γδ T Cell Subsets  to Stimulation with Cardiolipin and Zoledronate in Systemic Sclerosis

    Ilan Bank1, Paul Fisch2, Jose Villacorta Hidalgo3, Alexandra Balbir-Gurman4, Yolanda Braun-Moscovici5 and Helena Migalovich Sheikhet6, 1Medicine, Maayenei Hayeshuah and Chaim Sheba Medical Center, Israel, Bnei Brak, Israel, 23Department of Clinical Pathology, University of Freiburg Medical Center, Freiburg, Germany, 3Department of Clinical Pathology, University of Freiburg Medical Center, Freiburg, Germany, 4Rheumatology Unit, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel, Haifa, Israel, 5B Shine Department of Rheumatology, Rambam Health Care Campus,. Rappaport Faculty of Medicine, Technion, Haifa, Israel, 6Medicine, Laboratory of Immunoregulation, Chaim Sheba Medical Center, Ramat Gan, Israel

    Background/Purpose: Systemic sclerosis (SSc) is an auto-immune disorder  leading to destructive tissue fibrosis. Abnormal responses of  SSc T cells to lipid antigens and low molecular…
  • « Previous Page
  • 1
  • …
  • 1318
  • 1319
  • 1320
  • 1321
  • 1322
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology